In early 2025, Viking Therapeutics announced it was entering phase 2 clinical trials for its oral GLP-1 agonist and glucose-dependent insulinotropic polypeptide receptors, Viking VK2735
HINNAO Sublingual Glutathione offers a simple and convenient way to take glutathione in a clean liquid form
Executive summary: standards of medical care in diabetes2012
For people without deficiency, self-care should begin with basics that have stronger evidence: balanced meals, adequate protein, regular physical activity, hydration, sleep, and treatment of medical conditions that affect energy levels
Payers closely monitor off-label use
Chlebowski RT, Aragaki AK, Pan K